Literature DB >> 28915954

Do some epithelial ovarian cancers originate from a fallopian tube ciliate cell lineage?

Jan Rohozinski1, Conception Diaz-Arrastia2, Creighton L Edwards3.   

Abstract

There is a general agreement that a large subpopulation of serous ovarian cancers arise from the fallopian tube mucosal epithelium. However, there is still some debate as to whether the cancers originate from a secretory or ciliate cell lineage. One well established method for determining the origin of a cell line is to document the expression of genes and proteins that are cell type specific. Lineage or tissue specific patterns of gene expression are evidence of direct decent from a given cell type within a tissue. It has recently been established that the Tumor Protein TAp73 gene (TP73) is expressed in basal epithelial cells that develop into multiciliate cells. TP73 expression is therefore a marker for basal stem cells that are predestined to differentiate into cells with motile cilia and its expression is maintained in fully differentiated multiciliate cells. Interestingly TP73 expression has also been observed in a high percentage of epithelial ovarian cancers. With this in mind, it is hypothesized that a high percentage of epithelial ovarian cancers which express TP73 originate from a ciliate cell lineage.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CETN1; Epithelium; Fallopian tube; Motile cilia; Ovarian cancer; Ovary; Stems cells; TP73

Mesh:

Substances:

Year:  2017        PMID: 28915954     DOI: 10.1016/j.mehy.2017.07.014

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Exome-Wide Pan-Cancer Analysis of Germline Variants in 8,719 Individuals Finds Little Evidence of Rare Variant Associations.

Authors:  Zoe Guan; Ronglai Shen; Colin B Begg
Journal:  Hum Hered       Date:  2021-10-29       Impact factor: 0.444

2.  Identification of potential markers for differentiating epithelial ovarian cancer from ovarian low malignant potential tumors through integrated bioinformatics analysis.

Authors:  Wende Hao; Hongyu Zhao; Zhefeng Li; Jie Li; Jiahao Guo; Qi Chen; Yan Gao; Meng Ren; Xiaoting Zhao; Wentao Yue
Journal:  J Ovarian Res       Date:  2021-03-16       Impact factor: 4.234

3.  Adenylate kinase 7 is a prognostic indicator of overall survival in ovarian cancer.

Authors:  Xue-Ying Zhang; Li-Li Zhou; Yan Jiao; Yan-Qing Li; Yi-Nuo Guan; Yue-Chen Zhao; Lian-Wen Zheng
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.